bud mutation

bud mutation的基本解释

-

芽变

与bud mutation相关的网络例句 [注：此内容来源于网络，仅供参考]

YMDD mutation: HBV YMDD mutation were developed in 12 lamivudine recipients, whereas the treated group had no incidence of HBV YMDD variation, there were significant difference between two groups (p=0.000). YMDD mutation resulted in increase of the mean HBVDNA levels (p=0.000), but no contribution to serum ALT diversification (p＞0.05). 2. Precore nt1896 mutation: Precore nt1896 mutation incidence had no difference between lamivudine recipients and objects who received combination therapy of Kidney-invigorating Granule and Marine Injection, and patients of HBeAg negative and HBeAg positive had a close incidence of precore mutation as well as. Precore nt1896 mutation had no influence on serum ALT level. The occurrence of precore nt1896 mutation contributed to serum HBVDNA load increased and worse response of HBVDNA extenuation. 3. HBV genotype: The baseline of serum HBVDNA gradually increase in turn of genotype B, genotype C and genotype B/C. Genotype B seemed to obtain higher rate of serum HBVDNA loss and HBeAg/anti-HBe seroconversion after combination therapy of Kidney-invigorating Granule and Marine Injection, differencing with lamivudine therapy.

疗效相关因素研究：1YMDD变异：对照组有12例检出YMDD变异，治疗组无1例检出，两组比较有显著性差异（P=0.000）；发生YMDD变异者血清HBVDNA和ALT水平均有所升高，HBVDNA平均水平高于非变异者（P=0.000）；血清ALT与非变异者无明显差异（P＞0.05）。2前C区nt1896变异：前C区nt1896变异发生率在治疗组和对照组以及HBeAg阴性和HBeAg阳性患者之间均无明显差异（P＞0.05）；1896c变异对血清ALT水平无明显影响；治疗组发生1896c变异者，其HBVDNA平均水平较之未变异者明显升高（P＜0.05），治疗后HBVDNA下降幅度明显低于未发生1896c变异者（P=0.000）。3HBV基因型：血清HBVDNA基础水平在B、C、B/C混合型间存在明显差异（P＜0.05），按B型、C型、B/C混合型依次升高；治疗组HBVDNA阴转率、HBeAg/抗-HBe血清转换率，B型似乎高于C型和B/C混合型，但无统计学意义（P＞0.05）；对照组HBVDNA阴转、HBeAg/抗-HBe改变在B、C、B/C混合型间无明显差异（P＞0.05）。

It was investigated that the seasonal dynamics of bud bank, the effects of high sexual reproductive allocation on bud bank and daughter shoots, the changes of bud bank under different parent shoot density, C and N compound of apic ...更多 al rhizome bud response to bud bank seasonal dynamics, the effect of covering treatment during different growing phase on bud bank. The main results and conclusions were as follows:(1) Each bud type has distinct earliest timings to break. B1-1 begins to generate during late May, but B1-2, B2 and B3 occur during late June.

本文分别从羊草地下芽库的季节动态、高有性生殖分配对芽库的影响、不同基株密度条件下芽库及所生成子株的数量变化、根茎顶芽碳氮化合物在克隆生长中的重要作用以及不同阶段遮光处理对芽库数量的影响方面对羊草进行研究，得出的主要结果和结论如下：(1)每种类型芽都有不同的起始产生时间。

The result of uroscopy of the proband was strong positive. There was a novel deletion mutation of c.876-877 del TC in the coding region of exon 6 of IDS gene, which was a hemizygous mutation. However, the mutation of his mother and sister was a heterozygous mutation. Detection of the exon 6 of IDS gene showed that the mutation was not found among normal controls and other patients with MPS I, IV, and VI other than MPS II. Homology comparison of amino acid sequences from different species showed that the phenylalanine glutamine of the mutation site of c.876-877 del TC located in p.292-293 was highly conserved. The activity of IDS enzyme of the proband was only 2.3 nmol/4 h/mL, which was much lower than normal; but the activity of IDS enzyme of his father, mother and sister was 641.9 nmol/4 h/mL, 95.8 nmol/4h/mL and 103.2 nmol/4h/mL, respectively.

结果显示：先证者尿检呈强阳性；其IDS基因exon 6编码区内存在c.876-877 del TC新缺失突变，为半合子突变，而其母、其姐为杂合突变；正常对照和其他非II型MPS患者的IDS基因exon 6的检测结果均未发现该突变；不同物种氨基酸序列的同源性比对显示： c.876-877 del TC突变所在的位置即p.292-293的苯丙氨酸谷氨酰胺高度保守；酶活性测定的结果显示：先证者的IDS酶活性仅为2.3 nmol/4 h/mL，大大低于正常值，而其父的为641.9 nmol/4 h/mL，其母的血浆酶活性为95.8 nmol/ 4h/mL，其姐的为103.2 nmol/4 h/mL。

与bud mutation相关的网络解释 [注：此内容来源于网络，仅供参考]

bud sport bud mutation; bud variation：芽变

"芽条选择","bud selection" | "芽变","bud sport bud mutation; bud variation" | "芽变","bud variation bud mutation; bud sport"

bud mutation：芽变

Buchner funnel 布氏漏斗 | bud mutation 芽变 | budding 出芽,芽生,芽殖

bud mutation：芽突变

budding 出芽 | bud mutation 芽突变 | bud scar 芽痕

bud mutation, sport：芽变

突变协同作用 mutational synergism | 芽变 bud mutation, sport | 模拟突变体 mimic mutant

bud mutation, ort：芽变

突变协同作用 mutational synergism | 芽变 bud mutation, ort | 模拟突变体 mimic mutant